Common Contracts
11 similar Underwriting Agreement contracts by Alight, Inc. / Delaware, Adeptus Health Inc., Biomimetic Therapeutics, Inc., others
22,500,000 Shares Alight, Inc. Common Stock ($0.0001 Par Value) UNDERWRITING AGREEMENTUnderwriting Agreement • August 22nd, 2023 • Alight, Inc. / Delaware • Services-business services, nec
Certain stockholders named in Schedule I hereto (the “Selling Stockholders”) of Alight, Inc., a Delaware corporation (the “Company”), propose to sell to the several underwriters (the “Underwriters”) named on Schedule II hereto for whom you are acting as representatives (the “Representatives”) an aggregate of 22,500,000 shares (the “Firm Shares”) of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”). The respective amounts of the Firm Shares to be so purchased by the several Underwriters are set forth opposite their names on Schedule II hereto. In addition, the Selling Stockholders propose to grant to the Underwriters the option to purchase from the Selling Stockholders up to an additional an aggregate of up to 3,375,000 additional shares of the Company’s Common Stock (the “Option Shares”) as set forth below. The Firm Shares and the Option Shares (to the extent the aforementioned option is exercised) are herein collectively called the “Shares.” For the
46,000,000 Shares Alight, Inc. Common Stock ($0.0001 Par Value) UNDERWRITING AGREEMENTUnderwriting Agreement • March 6th, 2023 • Alight, Inc. / Delaware • Services-business services, nec
20,000,000 Shares Alight, Inc. Common Stock ($0.0001 Par Value) UNDERWRITING AGREEMENTUnderwriting Agreement • November 16th, 2022 • Alight, Inc. / Delaware • Services-business services, nec • New York
Certain stockholders named in Schedule I hereto (the “Selling Stockholders”) of Alight, Inc., a Delaware corporation (the “Company”), propose to sell to the several underwriters (the “Underwriters”) named on Schedule II hereto for whom you are acting as representatives (the “Representatives”) an aggregate of 20,000,000 shares (the “Firm Shares”) of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”). The respective amounts of the Firm Shares to be so purchased by the several Underwriters are set forth opposite their names on Schedule II hereto. In addition, the Selling Stockholders propose to grant to the Underwriters the option to purchase from the Selling Stockholders up to an additional an aggregate of up to 3,000,000 additional shares of the Company’s Common Stock (the “Option Shares”) as set forth below. The Firm Shares and the Option Shares (to the extent the aforementioned option is exercised) are herein collectively called the “Shares.” For the
8,000,000 Shares Verra Mobility Corporation Class A Common Stock ($0.0001 Par Value) EQUITY UNDERWRITING AGREEMENTUnderwriting Agreement • August 20th, 2021 • VERRA MOBILITY Corp • Transportation services • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • September 23rd, 2019 • Foundation Building Materials, Inc. • Wholesale-lumber & other construction materials • New York
LSF9 Cypress Parent 2 LLC, a Delaware limited liability company (the “Selling Stockholder”), proposes to sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representatives (the “Representatives”) an aggregate of 4,750,000 shares (the “Firm Shares”) of common stock, par value $0.001 per share (the “Common Stock”) of Foundation Building Materials, Inc., a Delaware corporation (the “Company”). The respective amounts of the Firm Shares to be so purchased by the several Underwriters are set forth opposite their names on Schedule I hereto. The Selling Stockholder also proposes to sell, at the Underwriters’ option, an aggregate of up to 712,500 additional shares of Common Stock (the “Option Shares”) as set forth below.
15,935,828 Shares SunEdison Semiconductor Limited Ordinary Shares (No Par Value) EQUITY UNDERWRITING AGREEMENTUnderwriting Agreement • June 30th, 2015 • SunEdison Semiconductor LTD • Semiconductors & related devices • New York
Certain shareholders named in Schedule II hereto (the “Selling Shareholders”) of SunEdison Semiconductor Limited, a company organized under the laws of the Republic of Singapore (the “Company”), propose to sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representatives (the “Representatives”) an aggregate of 15,935,828 shares (the “Shares”) of the Company’s ordinary shares, no par value (the “Ordinary Shares”). The respective amounts of the Shares to be so purchased by the several Underwriters are set forth opposite their names on Schedule I hereto, and the respective amounts to be sold by the Selling Shareholders are set forth opposite their names on Schedule II hereto.
2,100,000 Shares Adeptus Health Inc. Common Stock ($0.01 Par Value) UNDERWRITING AGREEMENTUnderwriting Agreement • May 11th, 2015 • Adeptus Health Inc. • Services-hospitals • New York
Adeptus Health Inc., a Delaware corporation (the “Company”) and SCP III AIV THREE-FCER Conduit, L.P. (the “Selling Stockholder”) propose to sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representatives (the “Representatives”), an aggregate of 2,100,000 shares (the “Firm Shares”) of the Company’s common stock, $0.01 par value (the “Common Stock”), of which 1,349,671 shares will be sold by the Company and 750,329 shares will be sold by the Selling Stockholder. The respective amounts of the Firm Shares to be so purchased by the several Underwriters are set forth opposite their names on Schedule I hereto. The Company and the Selling Stockholder also propose to sell at the Underwriters’ option an aggregate of up to 315,000 additional shares of the Company’s Common Stock (the “Option Shares”) as set forth below. The Company and the Selling Stockholder are sometimes referred to herein collectively as the “Sellers”.
Shares Adeptus Health Inc. Common Stock ($0.01 Par Value) UNDERWRITING AGREEMENTUnderwriting Agreement • May 4th, 2015 • Adeptus Health Inc. • Services-hospitals • New York
Adeptus Health Inc., a Delaware corporation (the “Company”) and SCP III AIV THREE-FCER Conduit, L.P. (the “Selling Stockholder”) propose to sell to the several underwriters (the “Underwriters”) named on Schedule I hereto for whom you are acting as representatives (the “Representatives”), an aggregate of shares (the “Firm Shares”) of the Company’s common stock, $0.01 par value (the “Common Stock”), of which shares will be sold by the Company and shares will be sold by the Selling Stockholder. The respective amounts of the Firm Shares to be so purchased by the several Underwriters are set forth opposite their names on Schedule I hereto. The Company and the Selling Stockholder also propose to sell at the Underwriters’ option an aggregate of up to additional shares of the Company’s Common Stock (the “Option Shares”) as set forth below. The Company and the Selling Stockholder are sometimes referred to herein collectively as the “Sellers”.
3,300,000 Shares GLOBAL EAGLE ENTERTAINMENT INC. Common Stock ($0.0001 Par Value) UNDERWRITING AGREEMENTUnderwriting Agreement • February 19th, 2015 • Global Eagle Entertainment Inc. • Communications services, nec • New York
The persons listed in Schedule II hereto (the “Selling Stockholders”), as stockholders of Global Eagle Entertainment Inc., a Delaware corporation (the “Company”), propose, subject to the terms and conditions stated herein, to sell to the several underwriters (the “Underwriters”) listed in Schedule I hereto for whom you are acting as representative (the “Representative”) an aggregate of 3,300,000 shares (the “Firm Shares”) of the Company’s common stock, $0.0001 par value (the “Common Stock”), with each Selling Stockholder selling the number of shares set forth opposite such Selling Stockholder’s name in the column “Total Number of Firm Shares to be Sold” in Schedule II hereto. In addition, at the option of the Underwriters, the Selling Stockholders propose to sell, subject to the terms and conditions stated herein, to the Underwriters up to an additional 495,000 shares of Common Stock (collectively, the “Optional Shares”) with each of the Selling Stockholders selling the number of share
4,391,000 Shares Physicians Formula Holdings, Inc. Common Stock ($0.01 Par Value) UNDERWRITING AGREEMENTUnderwriting Agreement • April 12th, 2007 • Physicians Formula Holdings, Inc. • Perfumes, cosmetics & other toilet preparations • New York
Certain stockholders of Physicians Formula Holdings, Inc., a Delaware corporation (the "Company") (the "Selling Stockholders") propose to sell to the several underwriters (the "Underwriters") named in Schedule I hereto for whom you are acting as representatives (the "Representatives") an aggregate of 4,391,000 shares (the "Firm Shares") of the Company's common stock, $.01 par value (the "Common Stock"). The respective amounts of the Firm Shares to be so purchased by the several Underwriters are set forth opposite their names in Schedule I hereto, and the respective amounts to be sold by the Selling Stockholders are set forth opposite their names in Schedule II hereto. The Selling Stockholders also propose to sell at the Underwriters' option an aggregate of up to 658,650 additional shares of the Company's Common Stock (the "Option Shares") as set forth on Schedule III hereto.
Shares BioMimetic Therapeutics, Inc. Common Stock ($0.001 Par Value) UNDERWRITING AGREEMENTUnderwriting Agreement • February 2nd, 2007 • Biomimetic Therapeutics, Inc. • Surgical & medical instruments & apparatus • New York
BioMimetic Therapeutics, Inc., a Delaware corporation (the “Company”), Samuel Lynch (“Selling Stockholder A”) and [____] (the “Other Selling Stockholders” and together with Selling Stockholder A, the “Selling Stockholders”) propose to sell to the several underwriters (the “Underwriters”) named in Schedule I hereto for whom you are acting as representatives (the “Representatives”) an aggregate of [___] shares (the “Firm Shares”) of the Company’s common stock, $0.001 par value (the “Common Stock”) of which [___] shares will be sold by the Company and [__] shares will be sold by the Selling Stockholders. The respective amounts of the Firm Shares to be so purchased by the several Underwriters are set forth opposite their names in Schedule I hereto and the respective amounts to be sold by the Selling Stockholders are set forth opposite their names on Schedule II. The Company and the Selling Stockholders are sometimes referred to herein collectively as the “Sellers”. The Company [and the Sel
